Nicole Stuendl
Grobming, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Correction: Sesquiterpene lactones downregulate G2/M cell cycle regulator proteins and affect the invasive potential of human soft tissue sarcoma cells.
Journal: PloS one
Published: February 17, 2026
Enhanced Osteogenic Differentiation of Human Primary Mesenchymal Stem and Progenitor Cultures on Graphene Oxide/Poly(methyl methacrylate) Composite Scaffolds.
Journal: Materials (Basel, Switzerland)
Published: June 04, 2020
Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 24, 2020
CoCrMo surface modifications affect biocompatibility, adhesion, and inflammation in human osteoblasts.
Journal: Scientific reports
Published: October 07, 2019
Mechanical exposure and diacerein treatment modulates integrin-FAK-MAPKs mechanotransduction in human osteoarthritis chondrocytes.
Journal: Cellular signalling
Published: November 05, 2018
Periplocin, the most anti-proliferative constituent of Periploca sepium, specifically kills liposarcoma cells by death receptor mediated apoptosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 15, 2018
Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 26, 2017
Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines.
Journal: Oncotarget
Published: January 31, 2017
Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Journal: Scientific reports
Published: August 15, 2016
Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation.
Journal: BMC cancer
Published: July 30, 2015
Last Updated: 09/26/2026